Jump to main content
Jump to site search

Issue 3, 2019
Previous Article Next Article

Rationally synthesized coumarin based pyrazolines ameliorate carrageenan induced inflammation through COX-2/pro-inflammatory cytokine inhibition

Author affiliations

Abstract

In the present work, coumarin based pyrazolines (7a–g) have been synthesized and investigated for their in vitro and in vivo anti-inflammatory potential. Amongst the synthesized compounds, compounds 7a, 7d and 7f exhibited significant in vitro anti-inflammatory activity as compared to the standard etoricoxib. Keeping this in mind, in vivo investigations were carried out via carrageenan induced inflammation and acetic acid induced writhing models in male Wistar rats and compound 7a was found to possess appreciable anti-inflammatory and analgesic potential. The mode of action of compound 7a was also investigated by using substance P as the biomarker, which shows promising results. Further, the selectivity of the most active compound 7a against the cyclooxygenase enzyme was supported by molecular docking studies which reveal that compound 7a has greater binding affinity towards COX-2 over COX-1 and 5-LOX enzymes. In silico ADME analysis of compound 7a confirms the drug-like characteristics and the in vivo acute toxicity study showed the safety of the compound even up to a 2000 mg kg−1 dose. Thus, compound 7a was identified as an effective anti-inflammatory agent, and can be explored for further analgesic/anti-inflammatory drug design and development.

Graphical abstract: Rationally synthesized coumarin based pyrazolines ameliorate carrageenan induced inflammation through COX-2/pro-inflammatory cytokine inhibition

Back to tab navigation

Supplementary files

Publication details

The article was received on 11 Sep 2018, accepted on 22 Jan 2019 and first published on 23 Jan 2019


Article type: Research Article
DOI: 10.1039/C8MD00457A
Citation: Med. Chem. Commun., 2019,10, 421-430

  •   Request permissions

    Rationally synthesized coumarin based pyrazolines ameliorate carrageenan induced inflammation through COX-2/pro-inflammatory cytokine inhibition

    P. Chandel, A. Kumar, N. Singla, A. Kumar, G. Singh and R. K. Gill, Med. Chem. Commun., 2019, 10, 421
    DOI: 10.1039/C8MD00457A

Search articles by author

Spotlight

Advertisements